Literature DB >> 26542542

Eradicating polio.

Anthony Adams1, David M Salisbury2.   

Abstract

Mesh：

Year:  2015        PMID： 26542542     DOI： 10.1126/science.aad7294

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  9 in total

1.  Prevalence of poliovirus vaccine strains in randomized stool samples from 2010 to 2018: encompassing transition from the trivalent to bivalent oral poliovirus vaccine.

Authors:  Jira Chansaenroj; Watchaporn Chuchaona; Thanundorn Thanusuwannasak; Ausanee Duang-In; Jiratchaya Puenpa; Viboonsak Vutithanachot; Sompong Vongpunsawad; Yong Poovorawan
Journal:  Virusdisease       Date:  2019-03-21

2.  Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial.

Authors:  Cynthia J Snider; Khalequ Zaman; Concepcion F Estivariz; Mohammad Yunus; William C Weldon; Kathleen A Wannemuehler; M Steven Oberste; Mark A Pallansch; Steven Gf Wassilak; Tajul Islam A Bari; Abhijeet Anand
Journal:  Lancet       Date:  2019-05-16       Impact factor: 79.321

3.  Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial.

Authors:  Khalequ Zaman; Stephanie D Kovacs; Kristin Vanderende; Asma Aziz; Mohammed Yunus; Sara Khan; Cynthia J Snider; Qian An; Concepcion F Estivariz; M Steven Oberste; Mark A Pallansch; Abhijeet Anand
Journal:  Vaccine       Date:  2021-09-02       Impact factor: 4.169

Review 4.  Intradermal vaccination for infants and children.

Authors:  Akihiko Saitoh; Yuta Aizawa
Journal:  Hum Vaccin Immunother       Date:  2016-05-02       Impact factor: 3.452

5.  Virologic Monitoring of Poliovirus Type 2 after Oral Poliovirus Vaccine Type 2 Withdrawal in April 2016 - Worldwide, 2016-2017.

Authors:  Ousmane M Diop; Humayun Asghar; Evgeniy Gavrilin; Nicksy Gumede Moeletsi; Gloria Rey Benito; Fem Paladin; Sirima Pattamadilok; Yan Zhang; Ajay Goel; Arshad Quddus
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-05-26       Impact factor: 17.586

6.  Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data.

Authors:  Margarita Pons-Salort; Natalie A Molodecky; Kathleen M O'Reilly; Mufti Zubair Wadood; Rana M Safdar; Andrew Etsano; Rui Gama Vaz; Hamid Jafari; Nicholas C Grassly; Isobel M Blake
Journal:  PLoS Med       Date:  2016-10-04       Impact factor: 11.069

7.  Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine.

Authors:  Isobel M Blake; Margarita Pons-Salort; Natalie A Molodecky; Ousmane M Diop; Paul Chenoweth; Ananda S Bandyopadhyay; Michel Zaffran; Roland W Sutter; Nicholas C Grassly
Journal:  N Engl J Med       Date:  2018-08-30       Impact factor: 91.245

8.  The problem of detrending when analysing potential indicators of disease elimination.

Authors:  Adjani Gama Dessavre; Emma Southall; Michael J Tildesley; Louise Dyson
Journal:  J Theor Biol       Date:  2019-04-11       Impact factor: 2.691

Review 9.  Why are vaccines against many human viral diseases still unavailable; an historic perspective?

Authors:  Gregory A Tannock; Hyunsuh Kim; Lumin Xue
Journal:  J Med Virol       Date:  2019-10-03       Impact factor: 2.327
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.